Hero Image

Innovation in Lung Cancer and Precision Medicine Research

Bristol-Myers Squibb and Nektar Therapeutics Enter Global Collaboration Agreement

Bristol-Myers Squibb and Nektar Therapeutics Enter Global Collaboration Agreement

The new $1.85 billion collaboration advances a strategic development partnership on a unique clinical-stage investigational immunotherapy agent.

Translating Science

Translating Science into Meaningful Outcomes for Patients 

Translational medicine is a collaborative bench-to-bedside-to-bench approach which incorporates multiple areas of basic research to better understand disease biology.

Harnessing the Power of Big Data to Drive Clinical Discovery

Harnessing the Power of Big Data to Drive Clinical Discovery

Researchers are generating and analyzing large volumes of data to help drive discovery in multiple disease areas.

Autoimmune Disease

Advancing Autoimmune Disease Research

Scientists are developing personalized medicine approaches in autoimmune diseases.


Our R&D Team

Bryan (Bo) Barnhart, Ph.D.

Bryan (Bo) Barnhart, Ph.D., Senior Director, Immuno-Oncology, Discovery

Leadership Insights

Tom Lynch, Chief Scientific Officer, Bristol-Myers Squibb


The New Collaboration Ecosystem: The Power of Many

Our Achievements

Our Achivements

We’re honored to be recognized as a Most Admired company by Fortune Magazine. For us, it’s all about working for patients.

Looking for Answers?

Quick links to helpful resources.

Clinical Trial Information for Researchers

Clinical trials and research are a critical part of bringing new medicines to patients.

Medical Information for Healthcare Providers

Information and resources to assist with caring for patients.